References
- Kupperman H S, Blatt M HG, Wiesbaden H, Filler W. Comparative clinical evaluation of estrogen preparations by the menopausal and amenorrhoeal indices. J Clin Endocrinol 1953; 13: 688–703
- Kupperman H S, Wetchler B B, Blatt M HG. Contemporary therapy of the menopausal syndrome. J Am Med Assoc 1959; 171: 1627–37
- Hauser G A, Huber I C, Keller P J, Lauritzen C, Schneider H PG. Evaluation der klimakterischen Beschwerden (Menopause Rating Scale (MRS)). Zentralbl Gynakol 1994; 116: 16–23
- Utian W H. Definitive symptoms of postmenopause – incorporating use of vaginal parabasal cell index. Estrogens in the Postmenopause. Frontiers of Hormone Research. Karger, Basel 1975; Vol. 3: 74–93
- Campbell S. Double blind psychometric studies on the effects of natural estrogens on postmenopausal women. The Management of the Menopause and Post-Menopausal Years, S Campbell. MTP Press, Lancaster 1975; 149–58
- Schneider H PG, Doeren M. Traits for long-term acceptance of hormone replacement therapy – results of a representative German survey. Eur Menopause J 1996; 3: 94–8
- Schneider H PG, Rosemeier H P, Schnitker J, Gerbsch S, Turck R. Application and factor analysis of the Menopause Rating Scale (MRS) in a post marketing surveillance study of Climen®. Maturitas 2000, submitted
- Schneider H PG, Schultz-Zehden B, Rosemeier H P, Behre H M. Assessing well-being in menopausal women. The Management of the Menopause – The Millennium Review 2000, J Studd. Parthenon Publishing, CarnforthUK 1999; 11–19
- Wiklund I. Methods of assessing the impact of climacteric complaints on quality of life. Maturitas 1998; 29: 41–50